T2 Biosystems (NASDAQ:TTOO) shares closed 11% lower Wednesday, marking another rocky session for the diagnostics developer, which expressed doubts in its most recent 10-Q report about its ability to ...

T2 Biosystems has received FDA clearance to add the capability to detect another bacterial species, Acinetobacter baumannii, to its panel. T2 Biosystems is set to report its fourth-quarter financial ...

LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the ...

Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...

LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...

LEXINGTON, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that the company will be hosting a special symposium highlighting the clinical and economic ...

LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the ...

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

T2 Biosystems Inc.’s stock fell 8.7% in premarket trades Friday as the developer of in vitro diagnostics products continued its pullback after ending Thursday’s session down 4.5% to snap a two-day ...

T2 Biosystems (NASDAQ:TTOO) stock is the top-trending ticker on social media, and its shares are up over 30% today after the Food and Drug Administration (FDA) allowed the company to start marketing ...